HBSP (USA)
-
Confidential Information for Elcer Products Division President (Spanish version)
Sebenius, James K.; Subramanian, GuhanCase HBS-910S03StrategyIn a six-party negotiation exercise, the TNDA Corp. plans to sell Elcer Products Division to one of four potential buyers (industrial, financial, U.S., German). This case contains confidential information for the Elcer Divisional management role. Challenges include how to set up and implement the most promising sales process, come up with the right deal, and choose the best tactical approach given each party's role and objectives. This negotiatio...Starting at €8.20
-
Tweeter etc. (Spanish version)
Gourville, John T.; Wu, GeorgeCase HBS-502S18MarketingIn the early 1990s, Tweeter etc., a small regional retailer of higher-end audio and video equipment, faced increasing competitive pricing pressures from several large regional and national consumer electronics chains. In response, in 1993, they introduced "Automatic Price Protection" (APP) as the cornerstone of a strategy to restore price credibility in the minds of consumers. Under APP, Tweeter monitored local newspaper ads and automatically mai...Starting at €8.20
-
Ti-Tech (B)
Shapiro, Benson P.; Gourville, John T.Case HBS-508096-EMarketingThis case concerns the selection and scheduling of orders by a small industrial titanium fabricator that recently has been plagued by poor deliveries and a lack of capacity. At the time of the case, Ti-Tech must decide which of four orders to accept, with capacity making it impossible to accept all four. Each order represents a different mix of labor, revenues, and potential future work. The case forces the student to choose among the four orders...Starting at €5.74
-
Hybrid Electric Vehicles: A 2011 Update
Gourville, John T.Case HBS-511125-EMarketingThis case is an addendum that updates HBS Case No. 502-025, "The Future of Hybrid Electric Cars." It covers the 10 years, 2001 to 2011.Starting at €8.20
-
Biopure Corp. (Spanish version)
Gourville, John T.Case HBS-502S01MarketingIt is early 1998 and Biopure Corp., a small biopharmaceutical firm with no sales revenues in its ten-year history, has just received government approval to release Oxyglobin, a revolutionary new "blood substitute" designed to replace the need for donated animal blood in the veterinary market. A virtually identical product for the human market, Hemopure, is in the final stages of testing by Biopure and is expected to gain approval within one to tw...Starting at €8.20
-
Cabot Pharmaceuticals, Inc. (Spanish version)
Cespedes, Frank V.; Gourville, John T.Case HBS-511S04MarketingTraces the 12-year career of a pharmaceutical salesperson, Bob Marsh, from recruitment to termination. Marsh has had an uneven career with Cabot Pharmaceuticals and eventually is asked to resign. Following his termination, a number of Marsh's former customers complain vigorously, and Cabot's vice president of sales is asked to investigate the matter and to decide what, if anything, to do about it. The case raises issues in aligning strategy and s...Starting at €8.20
-
New York Life and Immediate Annuities
Rotemberg, Julio J.; Gourville, John T.Case HBS-510040-EMarketingBy positioning Immediate Annuities as "guaranteed lifetime income," New York Life has built itself a $1.4 billion per year business by 2009. However, to make Immediate Annuities a mainstream financial product for retirees, New York Life must understand why many retirees are reluctant to buy them and many agents are reluctant to sell them.Starting at €8.20
-
The K-Dow Petrochemicals Joint Venture, Teaching Plan
Subramanian, Guhan; Krontiris, CharlotteTeaching Note HBS-913047-ETeaching Plan for case 912002.Starting at €0.00
-
Progress Energy and Duke Energy (B)
Subramanian, Guhan; Krontiris, CharlotteCase HBS-914012-EStarting at €5.74
-
An Activist Approach: Confidential Role Assignment for Castle Rock Management
Subramanian, Guhan; Szydlowski, KaitlynCase HBS-916012-EA three party, multiple-issue negotiation exercise dealing with a potential merger between two leading department stores, called for by an activist investor hedge fund in a letter to both companies. Company management will now attempt to navigate next moves, which are complicated by weak takeover defenses of their corporate boards, hedge fund ownership stake within both companies, and potential anti-trust risk. Meanwhile, the third party, the act...Starting at €8.20